The Alexion Pharmaceuticals, Inc. (ALXN) EVP Julie O'neill Sells 11160 Shares

Sivik Global Healthcare LLC now owns 110,000 shares valued at $13,384,000. Eqis Capital Management Inc. now owns 6,776 shares of the biopharmaceutical company's stock worth $824,000 after buying an additional 38 shares during the period. The company has market cap of $40.61 million. It closed at $83.93 lastly. It has outperformed by 6.79% the S&P500.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has been the object of insider selling activity recently. UBS AG reaffirmed a "buy" rating and set a $140.00 target price (down previously from $143.00) on shares of Alexion Pharmaceuticals in a research note on Wednesday, May 31st. Another trade for 1.35M shares valued at $156.92M was made by BAKER BROS. Trading volume was down 62.88% under the stocks average daily volume. Sector Gamma As holds 1.12% of its portfolio in Alexion Pharmaceuticals, Inc.

For this year, Alexion Pharmaceuticals, Inc. It has underperformed by 34.82% the S&P500.

Investors sentiment decreased to 0.77 in Q4 2016. Its up 0.23, from 1.14 in 2016Q3. 118 funds opened positions while 208 raised stakes. Private Ocean Lc has 0% invested in Deere & Company (NYSE:DE). Chilton Cap Management Llc owns 105,721 shares or 0.81% of their USA portfolio. Jane Street Grp Inc Ltd, a New York-based fund reported 92,452 shares. Moreover, Cadence Capital Management Ltd has 0.35% invested in Deere & Company (NYSE:DE). Maple Cap reported 1.76% in Deere & Company (NYSE:DE). Moreover, Cypress Capital Mngmt Limited Liability (Wy) has 0% invested in E I Du Pont De Nemours And Co (NYSE:DD) for 1,250 shares. Synovus Financial Corporation has 0.03% invested in Deere & Company (NYSE:DE). National Asset Mgmt reported 24,046 shares. The company was maintained on Thursday, July 27 by Cowen & Co. About 272,321 shares traded. 436 were accumulated by Independent Consultants. The company had a rise in short interest of 15.30% as of August 15, 2017 from the last reporting period.

The company is trading up by 2.86% since yesterday's close of $138.45. Current price places the company's stock -2.77% away from its 200-day simple moving average, -2.86%, away from the 50-day average and also 4.63% away from 20-day average. Therefore 44% are positive. Deere & Company had 87 analyst reports since July 27, 2015 according to SRatingsIntel. (NASDAQ:ALXN) has "Hold" rating given on Thursday, July 27 by Jefferies. The rating was upgraded by FBR Capital to "Mkt Perform" on Friday, October 28. The rating was upgraded by BMO Capital Markets to "Outperform" on Friday, April 29. That puts the market capitalization at $31.84 bln. Vetr has "Buy" rating and $213 target. Six equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company's stock. (NASDAQ:ALXN) on Wednesday, January 20 with "Neutral" rating. The rating was maintained by Stifel Nicolaus with "Buy" on Friday, June 23. Aviva Public Ltd Company holds 194,812 shares. The total value of its holdings increased 25.5%.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ALXN. 215.83 million shares or 2.26% more from 211.05 million shares in 2016Q3 were reported. 402,360 are held by Zevenbergen Invs Limited Liability Co.

AMC Networks Inc. (AMCX) Position Lowered by Federated Investors Inc. PA
Zooming in closer, company stock has been 14.29% for the quarter, -6.14% over the past month, and 0.43% over the past week. This repurchase authorization permits the company to reacquire up to 13.9% of its shares through open market purchases.

Gsa Capital Partners Llp decreased Alexion Pharmaceuticals Inc (ALXN) stake by 90.75% reported in 2016Q4 SEC filing. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since September 2, 2016 and is downtrending. Bessemer Grp reported 0% of its portfolio in Alexion Pharmaceuticals, Inc. Geneva Lc holds 13,356 shares. Sumitomo Life Insur has 9,843 shares. Nomura Holdings Inc holds 0.01% or 32,350 shares in its portfolio. Tyrus Sam accumulated 0.31% or 10,000 shares. Bb&T Securities Ltd Co holds 0.02% or 11,934 shares. Leavell Invest Mngmt Inc has 11,000 shares for 0.19% of their portfolio. Citigroup maintained Alexion Pharmaceuticals, Inc. Stewart & Patten Communications Limited Liability owns 3,410 shares or 0.07% of their USA portfolio. Louisiana State Employees Retirement Sys holds 0.09% of its portfolio in Alexion Pharmaceuticals, Inc. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 91,702 shares.

Alexion Pharmaceuticals, Inc. has a 1-year low of $96.18 and a 1-year high of $145.41. Alexion Pharmaceuticals had a return on equity of 12.47% and a net margin of 15.31%.

Since March 2, 2017, it had 4 insider buys, and 1 sale for $235.75 million activity.

Analyst Thoughts About Alexion Pharmaceuticals, Inc. Reed Cory J sold $688,923 worth of stock or 5,601 shares. ADVISORS LP on Wednesday, June 14. As per Wednesday, June 14, the company rating was maintained by Oppenheimer.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Latest News